Revisiting PC1/3 mutants: Dominant-negative effect of endoplasmic reticulum-retained mutants

Endocrinology

Volumn 156, Issue 10, 2015, Pages 3625-3637

  Blanco, Elias H ^a   Ramos Molina, Bruno ^a   Lindberg, Iris ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROPROTEIN CONVERTASE 1; MUTANT PROTEIN; PROTEIN BINDING;

ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LYSATE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; EXPRESSION VECTOR; GOLGI COMPLEX; HEK293 CELL LINE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MIN6 CELL LINE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SITE DIRECTED MUTAGENESIS; ANIMAL; BIOCATALYSIS; ENZYMOLOGY; GENETICS; GENOTYPE; METABOLISM; MUTATION; PROTEIN DEGRADATION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; BIOCATALYSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GENOTYPE; HEK293 CELLS; HUMANS; MICE; MICROSCOPY, CONFOCAL; MUTANT PROTEINS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPROTEIN CONVERTASE 1; PROTEIN BINDING; PROTEOLYSIS;

EID: 84943593082     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1068     Document Type: Article

References (46)

1. Rouillé Y, Duguay SJ, Lund K, et al. Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisinlike proprotein convertases. Front Neuroendocrinol. 1995;16:322-361.
2. Hoshino A, Lindberg I. Prohormone convertases 1/3 and 2. In: Fricker LD, Devi L, eds. Peptide Biosynthesis. Princeton, NJ: Morgan& Claypool Life Sciences Publishers; 2012.
3. Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet. 1997;16:303-306.
4. Jackson RS, Creemers JW, Farooqi IS, et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest. 2003;112:1550-1560.
5. Farooqi IS, Volders K, Stanhope R, et al. Hyperphagia and earlyonset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. J Clin Endocrinol Metab. 2007;92:3369-3373.
6. Martn MG, Lindberg I, Solorzano-Vargas RS, et al. Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort. Gastroenterology. 2013;145:138-148.
7. Philippe J, Stijnen P, Meyre D, et al. A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity. Int J Obes (Lond). 2015;39:295-302.
8. Wilschanski M, Abbasi M, Blanco E, et al.Anovel familial mutation in thePCSK1gene that alters the oxyanion hole residue of proprotein convertase 1/3 and impairs its enzymatic activity. PLoS One. 2014; 9:e108878.
9. Lloyd DJ, Bohan S, Gekakis N. Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice. Hum Mol Genet. 2006; 15:1884-1893.
10. Gjesing AP, Vestmar MA, Jorgensen T, et al. The effect of PCSK1 variants on waist, waist-hip ratio and glucose metabolism is modified by sex and glucose tolerance status. PLoSOne. 2011;6:e23907.
11. Stijnen P, Tuand K, Varga TV, Franks PW, Aertgeerts B, Creemers JW. The association of common variants in PCSK1 with obesity: a HuGE review and meta-analysis.AmJ Epidemiol. 2014;180:1051-1065.
12. Benzinou M, Creemers JW, Choquet H, et al. Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet. 2008; 40:943-945.
13. Choquet H, Kasberger J, Hamidovic A, Jorgenson E. Contribution ofcommonPCSK1 genetic variants to obesity in 8,359 subjects from multi-ethnic American population. PLoS One. 2013;8:e57857.
14. Mbikay M, Sirois F, Nkongolo KK, Basak A, Chrétien M. Effects of rs6234/rs6235 and rs6232/rs6234/rs6235 PCSK1 single-nucleotide polymorphism clusters on proprotein convertase 1/3 biosynthesis and activity. Mol Genet Metab. 2011;104:682-687.
15. Creemers JW, Choquet H, Stijnen P, et al. Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity. Diabetes. 2012;61:383-390.
16. Pickett LA, Yourshaw M, Albornoz V, et al. Functional consequences of a novel variant of PCSK1. PLoS One. 2013;8:e55065.
17. Creemers JW, Roebroek AJ, Van de Ven WJ. Expression in human lung tumor cells of the proprotein processing enzyme PC1/PC3. Cloning and primary sequence of a 5 kb cDNA. FEBS Lett. 1992; 300:82-88.
18. Blanco EH, Peinado JR, Martn MG, Lindberg I. Biochemical and cell biological properties of the human prohormone convertase 1/3 Ser357Gly mutation: a PC1/3 hypermorph. Endocrinology. 2014; 155:3434-3447.
19. Lindberg I. Evidence for cleavage of the PC1/PC3 pro-segment in the endoplasmic reticulum. Mol Cell Neurosci. 1994;5:263-268.
20. Zhou Y, Lindberg I. Enzymatic properties of carboxyl-terminally truncated prohormone convertase 1 (PC1/SPC3) and evidence for autocatalytic conversion. J Biol Chem. 1994;269:18408-18413.
21. Dikeakos JD, Di Lello P, Lacombe MJ, et al. Functional and structural characterization of a dense core secretory granule sorting domain from the PC1/3 protease. Proc Natl Acad Sci USA. 2009;106: 7408-7413.
22. Kuliawat R, Prabakaran D, Arvan P. Proinsulin endoproteolysis confers enhanced targeting of processed insulin to the regulated secretory pathway. Mol Biol Cell. 2000;11:1959-1972.
23. Mulcahy LR, Vaslet CA, Nillni EA. Prohormone-convertase 1 processing enhances post-Golgi sorting of prothyrotropin-releasing hormone-derived peptides. J Biol Chem. 2005;280:39818-39826.
24. Malosio ML, Giordano T, Laslop A, Meldolesi J. Dense-core granules: a specific hallmark of the neuronal/neurosecretory cell phenotype. J Cell Sci. 2004;117:743-749.
25. WangJ, Takeuchi T, Tanaka S, et al.Amutation in the insulin 2 gene induces diabetes with severe pancreatic β-cell dysfunction in the Mody mouse. J Clin Invest. 1999;103:27-37.
26. Lee MS, Wajnrajch MP, Kim SS, et al. Autosomal dominant growth hormone (GH) deficiency type II: the Del32-71-GH deletion mutant suppresses secretion of wild-type GH. Endocrinology. 2000;141: 883-890.
27. Ito M, Yu RN, Jameson JL. Mutant vasopressin precursors that cause autosomal dominant neurohypophyseal diabetes insipidus retain dimerization and impair the secretion of wild-type proteins. J Biol Chem. 1999;274:9029-9037.
28. Wright J, Wang X, Haataja L, et al. Dominant protein interactions that influence the pathogenesis of conformational diseases. J Clin Invest. 2013;123:3124-3134.
29. Prabhu Y, Blanco EH, LiuM,et al. Defective transport of the obesity mutant PC1/3 N222D contributes to loss of function. Endocrinology. 2014;155:2391-2401.
30. Blanco EH, Zñiga JP, Andrés ME, Alvarez AR, Gysling K. Corticotropin-releasing factor binding protein enters the regulated secretory pathway in neuroendocrine cells and cortical neurons. Neuropeptides. 2011;45:273-279.
31. Oyadomari S, Koizumi A, Takeda K, et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest. 2002;109:525-532.
32. Rajan S, Eames SC, Park SY, et al. In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetes. Am J Physiol Endocrinol Metab. 2010;298:E403-E410.
33. Blanco EH, Lagos CF, AndresME,Gysling K.Anamphipathicβ-helix in the prodomain of cocaine and amphetamine regulated transcript peptide precursor serves as its sorting signal to the regulated secretory pathway. PLoS One. 2013;8:e59695.
34. Bolte S, Cordelières FP.Aguided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224:213-232.
35. Manders EM, Stap J, Brakenhoff GJ, van Driel R, Aten JA. Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy. J Cell Sci. 1992;103(pt 3):857-862.
36. van Steensel B, van Binnendijk EP, Hornsby CD, et al. Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. J Cell Sci. 1996;109(pt 4):787-792.
37. Sirois F, Kaefer N, Currie KA, Chrétien M, Nkongolo KK, Mbikay M. Allelic clustering and ancestry-dependent frequencies of rs6232, rs6234, and rs6235 PCSK1 SNPs in a Northern Ontario population sample. J Community Genet. 2012;3:319-322.
38. Zhu X, Lindberg I. 7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expression of enzymatic activity. J Cell Biol. 1995;129:1641-1650.
39. Hoshino A, Kowalska D, Jean F, Lazure C, Lindberg I. Modulation of PC1/3 activity by self-interaction and substrate binding. Endocrinology. 2011;152:1402-1411.
40. Boslem E, Weir JM, MacIntosh G, et al. Alteration of endoplasmic reticulum lipid rafts contributes to lipotoxicity in pancreatic β-cells. J Biol Chem. 2013;288:26569-26582.
41. Milgram SL, Mains RE. Differential effects of temperature blockade on the proteolytic processing of three secretory granule-associated proteins. J Cell Sci. 1994;107(pt 3):737-745.
42. Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature. 2008;454:455-462.
43. Liu M, Hodish I, Rhodes CJ, Arvan P. Proinsulin maturation, misfolding, and proteotoxicity. Proc Natl Acad Sci USA. 2007;104: 15841-15846.
44. Izumi T, Yokota-Hashimoto H, Zhao S, Wang J, Halban PA, Takeuchi T. Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. Diabetes. 2003;52:409-416.
45. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. Dynamic interaction of BiP and ER stress transducers in the unfoldedprotein response. Nat Cell Biol. 2000;2:326-332.
46. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell. 2001; 107:881-891.